Preclinical Models Highlight Utility of Peripheral CB1 Inhibition

At ECO 2025, Skye presented its poster: “Demonstrating the sufficiency of peripheral CB1 inhibition to promote weight loss using clinical pharmacokinetic and pharmacodynamic models.”